• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-吡唑并[3,4-d]嘧啶类化合物的合成及其生物医学应用

1-Pyrazolo[3,4-]pyridines: Synthesis and Biomedical Applications.

机构信息

Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain.

出版信息

Molecules. 2022 Mar 30;27(7):2237. doi: 10.3390/molecules27072237.

DOI:10.3390/molecules27072237
PMID:35408636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9000541/
Abstract

Pyrazolo[3,4-]pyridines are a group of heterocyclic compounds presenting two possible tautomeric forms: the 1- and 2-isomers. More than 300,000 1-pyrazolo[3,4-]pyridines have been described which are included in more than 5500 references (2400 patents) up to date. This review will cover the analysis of the diversity of the substituents present at positions N1, C3, C4, C5, and C6, the synthetic methods used for their synthesis, starting from both a preformed pyrazole or pyridine, and the biomedical applications of such compounds.

摘要

吡唑并[3,4-d]吡啶是一类杂环化合物,具有两种可能的互变异构形式:1-和 2-异构体。迄今为止,已经描述了超过 300,000 种 1-吡唑并[3,4-d]吡啶,这些化合物被收录在超过 5500 篇参考文献(2400 项专利)中。这篇综述将涵盖对 N1、C3、C4、C5 和 C6 位置上取代基的多样性进行分析,以及用于合成它们的合成方法,包括从预先形成的吡唑或吡啶开始,以及这些化合物的生物医学应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/edc4df59f2c9/molecules-27-02237-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b2242779531f/molecules-27-02237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/cbc86c957f64/molecules-27-02237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/d107af583638/molecules-27-02237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/a53e5a141232/molecules-27-02237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f5722d27b3a8/molecules-27-02237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/68560c0b6e4d/molecules-27-02237-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/151da185a54a/molecules-27-02237-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/170710646efb/molecules-27-02237-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/c6e5e2f6fa15/molecules-27-02237-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/1636ddbff80c/molecules-27-02237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/bb7c1e3102b0/molecules-27-02237-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/2e7ec1c22e79/molecules-27-02237-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/33a5653bd778/molecules-27-02237-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/834bcacf75c8/molecules-27-02237-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/ae21656a9be7/molecules-27-02237-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/833b61310a6a/molecules-27-02237-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/8f2519838f7a/molecules-27-02237-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/750029685140/molecules-27-02237-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f1c094a6eebb/molecules-27-02237-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b5e0399729d1/molecules-27-02237-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/57cf6316f7fc/molecules-27-02237-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/0456f7c06cf7/molecules-27-02237-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/d61f13c30f46/molecules-27-02237-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b8cd5e187af5/molecules-27-02237-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f4cf00dea207/molecules-27-02237-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/2b7a1a190d2f/molecules-27-02237-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/edc4df59f2c9/molecules-27-02237-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b2242779531f/molecules-27-02237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/cbc86c957f64/molecules-27-02237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/d107af583638/molecules-27-02237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/a53e5a141232/molecules-27-02237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f5722d27b3a8/molecules-27-02237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/68560c0b6e4d/molecules-27-02237-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/151da185a54a/molecules-27-02237-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/170710646efb/molecules-27-02237-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/c6e5e2f6fa15/molecules-27-02237-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/1636ddbff80c/molecules-27-02237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/bb7c1e3102b0/molecules-27-02237-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/2e7ec1c22e79/molecules-27-02237-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/33a5653bd778/molecules-27-02237-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/834bcacf75c8/molecules-27-02237-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/ae21656a9be7/molecules-27-02237-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/833b61310a6a/molecules-27-02237-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/8f2519838f7a/molecules-27-02237-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/750029685140/molecules-27-02237-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f1c094a6eebb/molecules-27-02237-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b5e0399729d1/molecules-27-02237-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/57cf6316f7fc/molecules-27-02237-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/0456f7c06cf7/molecules-27-02237-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/d61f13c30f46/molecules-27-02237-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/b8cd5e187af5/molecules-27-02237-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/f4cf00dea207/molecules-27-02237-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/2b7a1a190d2f/molecules-27-02237-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f530/9000541/edc4df59f2c9/molecules-27-02237-g035.jpg

相似文献

1
1-Pyrazolo[3,4-]pyridines: Synthesis and Biomedical Applications.1-吡唑并[3,4-d]嘧啶类化合物的合成及其生物医学应用
Molecules. 2022 Mar 30;27(7):2237. doi: 10.3390/molecules27072237.
2
1,6-Naphthyridin-2(1)-ones: Synthesis and Biomedical Applications.1,6-萘啶-2(1)-酮:合成与生物医学应用
Pharmaceuticals (Basel). 2021 Oct 9;14(10):1029. doi: 10.3390/ph14101029.
3
Differentiation of regioisomeric N-alkylation of some indazoles and pyrazolopyridines by advanced NMR techniques.运用先进的核磁共振技术区分某些吲唑和吡唑并吡啶的区域异构N-烷基化反应
Magn Reson Chem. 2024 Nov;62(11):765-774. doi: 10.1002/mrc.5471. Epub 2024 Jul 14.
4
Synthesis of some new pyrazolo[1,5-a]pyrimidine, pyrazolo[5,1-c]triazine, 1,3,4-thiadiazole and pyridine derivatives containing 1,2,3-triazole moiety.一些含1,2,3-三唑部分的新型吡唑并[1,5-a]嘧啶、吡唑并[5,1-c]三嗪、1,3,4-噻二唑和吡啶衍生物的合成。
Chem Cent J. 2017 Jun 12;11(1):53. doi: 10.1186/s13065-017-0282-4.
5
Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agents.有机金属 3-(1H-苯并咪唑-2-基)-1H-吡唑并[3,4-b]吡啶类化合物作为潜在的抗癌剂。
Inorg Chem. 2011 Nov 21;50(22):11715-28. doi: 10.1021/ic201704u. Epub 2011 Oct 27.
6
Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.针对耐甲氧西林表皮葡萄球菌临床菌株的抗菌谱以及1H-吡唑并[3,4-b]吡啶和噻吩并[2,3-b]吡啶衍生物的构效关系研究
Bioorg Med Chem. 2008 Sep 1;16(17):8196-204. doi: 10.1016/j.bmc.2008.07.035. Epub 2008 Jul 20.
7
Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines.2,4-或2,6-二取代以及2,4,6-三取代-2H-吡唑并[4,3-c]吡啶的合成及其抗有丝分裂活性
Eur J Med Chem. 2018 Apr 25;150:908-919. doi: 10.1016/j.ejmech.2018.03.037. Epub 2018 Mar 16.
8
Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.一些新型吡唑并[1,5-a]嘧啶和吡唑并[5,1-c][1,2,4]三嗪的合成、表征、抗菌活性和抗癌活性。
Med Chem. 2020;16(6):750-760. doi: 10.2174/1573406415666190620144404.
9
Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors.发现 3,6-二芳基-1H-吡唑并[3,4-b]吡啶类化合物作为有效的间变性淋巴瘤激酶(ALK)抑制剂。
Bioorg Med Chem Lett. 2019 Apr 1;29(7):912-916. doi: 10.1016/j.bmcl.2019.01.037. Epub 2019 Feb 1.
10
Synthesis of 3,6-diaryl-1-pyrazolo[3,4-]pyridines one-pot sequential Suzuki-Miyaura coupling.3,6-二芳基-1-吡唑并[3,4-]吡啶的合成——一锅法连续铃木-宫浦偶联反应
RSC Adv. 2018 Oct 11;8(61):34883-34894. doi: 10.1039/c8ra07104g. eCollection 2018 Oct 10.

引用本文的文献

1
Recent advances in pyrazolo[3,4-b]pyridine chemistry: synthesis techniques and biological activity.吡唑并[3,4 - b]吡啶化学的最新进展:合成技术与生物活性
Mol Divers. 2025 Jun 25. doi: 10.1007/s11030-025-11231-5.
2
The Role of Flow Chemistry on the Synthesis of Pyrazoles, Pyrazolines and Pyrazole-Fused Scaffolds.流动化学在吡唑、吡唑啉及吡唑稠合骨架合成中的作用
Molecules. 2025 Apr 2;30(7):1582. doi: 10.3390/molecules30071582.
3
Synthesis and Neurotropic Activity of New 5-Piperazinopyrazolo[3,4-]-2,7-naphthyridines and Isoxazolo[5,4-]-2,7-naphthyridines.

本文引用的文献

1
Synthesis of 3,6-diaryl-1-pyrazolo[3,4-]pyridines one-pot sequential Suzuki-Miyaura coupling.3,6-二芳基-1-吡唑并[3,4-]吡啶的合成——一锅法连续铃木-宫浦偶联反应
RSC Adv. 2018 Oct 11;8(61):34883-34894. doi: 10.1039/c8ra07104g. eCollection 2018 Oct 10.
2
One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.一锅法三组分合成新型吡唑并[3,4-b]吡啶类化合物作为有效的抗白血病药物。
Eur J Med Chem. 2022 Jan 5;227:113952. doi: 10.1016/j.ejmech.2021.113952. Epub 2021 Oct 29.
3
Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists.
新型5-哌嗪基吡唑并[3,4 - ] - 2,7 - 萘啶和异恶唑并[5,4 - ] - 2,7 - 萘啶的合成及其神经活性
Pharmaceuticals (Basel). 2025 Apr 19;18(4):597. doi: 10.3390/ph18040597.
4
Regioselective cyclocondensations with thiobarbituric acid: spirocyclic and azocine products, X-ray characterization, and antioxidant evaluation.与硫代巴比妥酸的区域选择性环缩合反应:螺环和氮杂环辛四烯产物、X射线表征及抗氧化性能评估
RSC Adv. 2025 Mar 19;15(11):8609-8621. doi: 10.1039/d4ra07966c. eCollection 2025 Mar 17.
5
Bioactive Fused Pyrazoles Inspired by the Adaptability of 5-Aminopyrazole Derivatives: Recent Review.受5-氨基吡唑衍生物适应性启发的生物活性稠合吡唑:近期综述
Molecules. 2025 Jan 17;30(2):366. doi: 10.3390/molecules30020366.
6
Isomerization of pirazolopyrimidines to pyrazolopyridines by ring-opening/closing reaction in aqueous NaOH.在氢氧化钠水溶液中,吡唑并嘧啶通过开环/闭环反应异构化为吡唑并吡啶。
RSC Adv. 2025 Jan 22;15(3):2078-2085. doi: 10.1039/d4ra06345g. eCollection 2025 Jan 16.
7
Comprehensive Insight into Green Synthesis Approaches, Structural Activity Relationship, and Therapeutic Potential of Pyrazolic Chalcone Derivative.对吡唑基查尔酮衍生物的绿色合成方法、构效关系及治疗潜力的全面洞察。
Mini Rev Med Chem. 2025;25(7):539-577. doi: 10.2174/0113895575327555241024111038.
8
Unexpected discovery: "A new 3,3'-bipyrazolo[3,4-]pyridine scaffold and its comprehensive analysis".意外发现:“一种新型3,3'-联吡唑并[3,4-]吡啶支架及其综合分析”
Heliyon. 2024 Jun 6;10(11):e32573. doi: 10.1016/j.heliyon.2024.e32573. eCollection 2024 Jun 15.
9
Comprehensive analysis of crystal structure, spectroscopic properties, quantum chemical insights, and molecular docking studies of two pyrazolopyridine compounds: potential anticancer agents.两种吡唑并吡啶化合物的晶体结构、光谱性质、量子化学见解及分子对接研究的综合分析:潜在抗癌剂
RSC Adv. 2023 Oct 16;13(43):30118-30128. doi: 10.1039/d3ra04874h. eCollection 2023 Oct 11.
10
Synthesis and In Vitro Anticancer Activity of Novel 4-Aryl-3-(4-methoxyphenyl)-1-phenyl-1-pyrazolo[3,4-]pyridines Arrest Cell Cycle and Induce Cell Apoptosis by Inhibiting CDK2 and/or CDK9.新型 4-芳基-3-(4-甲氧基苯基)-1-苯基-1-吡唑并[3,4-]吡啶的合成及其体外抗癌活性通过抑制 CDK2 和/或 CDK9 来抑制细胞周期并诱导细胞凋亡。
Molecules. 2023 Sep 4;28(17):6428. doi: 10.3390/molecules28176428.
新型 5-氟尿嘧啶增敏剂用于结直肠癌治疗:S1P 受体 2(S1PR2)拮抗剂的设计与合成。
Eur J Med Chem. 2022 Jan 5;227:113923. doi: 10.1016/j.ejmech.2021.113923. Epub 2021 Oct 15.
4
Pimitespib is effective on cecal GIST in a mouse model of familial GISTs with KIT-Asp820Tyr mutation through KIT signaling inhibition.皮米替尼对携 KIT-Asp820Tyr 突变的家族性 GIST 小鼠模型的盲肠 GIST 有效,其作用机制是通过抑制 KIT 信号通路。
Exp Mol Pathol. 2021 Dec;123:104692. doi: 10.1016/j.yexmp.2021.104692. Epub 2021 Oct 1.
5
Triethylammonium Hydrogen Sulfate [EtNH][HSO]-Catalyzed Rapid and Efficient Multicomponent Synthesis of Pyrido[2,3-]pyrimidine and Pyrazolo[3,4-]pyridine Hybrids.硫酸氢三乙铵[EtNH][HSO]催化快速高效合成吡啶并[2,3 - ]嘧啶和吡唑并[3,4 - ]吡啶杂化物
ACS Omega. 2021 Jul 2;6(28):18215-18225. doi: 10.1021/acsomega.1c02093. eCollection 2021 Jul 20.
6
Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors.新型 1H-吡唑并[3,4-b]吡啶衍生物的合成及其作为 DYRK1A/1B 抑制剂的活性评价。
Bioorg Med Chem Lett. 2021 Sep 1;47:128226. doi: 10.1016/j.bmcl.2021.128226. Epub 2021 Jun 26.
7
Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration.设计和合成靶向丝裂原活化蛋白激酶激酶 4(MKK4)的 1H-吡唑并[3,4-b]吡啶类化合物——肝再生有前景的治疗靶点。
Eur J Med Chem. 2021 Jun 5;218:113371. doi: 10.1016/j.ejmech.2021.113371. Epub 2021 Mar 17.
8
Vericiguat: First Approval.维立西呱:首次批准。
Drugs. 2021 Apr;81(6):721-726. doi: 10.1007/s40265-021-01496-z.
9
Synthesis of novel pyrazolo[3,4-b]quinolinebisphosphonic acids and an unexpected intramolecular cyclization and phosphonylation reaction.新型吡唑并[3,4-b]喹啉双膦酸的合成及意想不到的分子内环化和膦酰化反应。
Org Biomol Chem. 2021 Mar 21;19(11):2533-2545. doi: 10.1039/d1ob00025j. Epub 2021 Mar 5.
10
Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.设计、合成并评价吲唑衍生物作为选择性和强效 FGFR4 抑制剂用于治疗 FGF19 驱动的肝细胞癌。
Eur J Med Chem. 2021 Mar 15;214:113219. doi: 10.1016/j.ejmech.2021.113219. Epub 2021 Jan 29.